Altimmune, Inc. insider trading activity
Understanding Insider Activity at Altimmune, Inc.
Welcome to our dedicated page for Altimmune, Inc. (Nasdaq: ALT) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Altimmune, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Altimmune, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for ALT| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| ALT | 10:05:08 PM 8/20/2024 | Drutz David sold 16011 shares of Altimmune, Inc. (ALT) for ~$110546 | Filing |
| ALT | 10:46:57 PM, 8/15/2023 | Drutz David purchased 300 shares of Altimmune, Inc. (ALT) for ~$864 | Filing |
| ALT | 10:00:14 PM 7/6/2023 | GILL JOHN sold 2714 shares of Altimmune, Inc. (ALT) for ~$40710 | Filing |
| ALT | 9:17:23 PM, 3/27/2023 | Drutz David purchased 9000 shares of Altimmune, Inc. (ALT) for ~$38429 | Filing |
| ALT | 12:54:49 AM, 3/25/2023 | Eisenstadt Richard I(Chief Financial Officer) purchased 10000 shares of Altimmune, Inc. (ALT) for ~$43099 | Filing |
| ALT | 12:28:29 AM, 3/24/2023 | Harris Matthew Scott(Chief Medical Officer) purchased 10000 shares of Altimmune, Inc. (ALT) for ~$42200 | Filing |
| ALT | 9:05:36 PM 12/22/2022 | Pisano Wayne sold 20000 shares of Altimmune, Inc. (ALT) for ~$300200 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 7 insider filings.
Register now to dive deeper and explore the full dataset.